Literature DB >> 19679237

Lobomycosis: diagnosis and management of relapsed and multifocal lesions.

Fabiana Pirani Carneiro1, Lívia Bravo Maia, Mário Augusto P Moraes, Albino Verçosa de Magalhães, Leonora Maciel de S Vianna, Pedro C Q Zancanaro, Carmélia Matos Reis.   

Abstract

We report a case of lobomycosis in the left leg of a patient that had traveled to the endemic Brazilian Amazon region. After surgical resection of the lesion, there was relapse with local dissemination of the disease and the treatment was successfully performed by oral itraconazole and cryosurgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679237     DOI: 10.1016/j.diagmicrobio.2009.04.013

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  Lobomycosis successfully treated with posaconazole.

Authors:  Beatriz Bustamante; Carlos Seas; Martín Salomon; Francisco Bravo
Journal:  Am J Trop Med Hyg       Date:  2013-04-01       Impact factor: 2.345

2.  Subcutaneous Mycoses in Travelers.

Authors:  Andrés Tirado-Sánchez; Carlos Franco-Paredes; Alexandro Bonifaz
Journal:  Curr Trop Med Rep       Date:  2020-11-06

Review 3.  Lobomycosis: epidemiology, clinical presentation, and management options.

Authors:  Valeska Albuquerque Francesconi; Ana Paula Klein; Ana Paula Botelho Gualda Santos; Rajendranath Ramasawmy; Fábio Francesconi
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

4.  Lobomycosis: a therapeutic challenge.

Authors:  Marcelo Grossi Araújo; Nathalie Silva Cirilo; Soraya Neves Marques Barbosa Dos Santos; Claudemir Roberto Aguilar; Antonio Carlos Martins Guedes
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

5.  Lobomycosis: exuberant presentation with malignant transformation.

Authors:  Wanessa da Costa Lima; Sidharta Quercia Gadelha; Mara Lúcia Gomes de Souza; Virginia Vilasboas Figueiras
Journal:  An Bras Dermatol       Date:  2021-09-25       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.